Tony Butler
Stock Analyst at Rodman & Renshaw
(0.76)
# 3,869
Out of 4,944 analysts
105
Total ratings
32.35%
Success rate
-13.82%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $11.54 | +116.64% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $3.25 | +238.46% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.65 | +990.91% | 4 | Sep 26, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $15 | $1.66 | +803.61% | 1 | Jun 28, 2024 | |
| LPTX Leap Therapeutics | Initiates: Buy | $8 | $0.32 | +2,373.72% | 1 | Jun 28, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $0.52 | +2,988.80% | 5 | Aug 10, 2023 | |
| ADAP Adaptimmune Therapeutics | Reiterates: Buy | $10 | $0.08 | +12,920.83% | 8 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $0.94 | +968.03% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $56.60 | +32.51% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $63.76 | -45.11% | 7 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $60 | $1.75 | +3,329.75% | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.47 | +784.35% | 6 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $7.22 | +592.52% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.03 | +1,356.31% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.37 | +6,654.93% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.04 | +1,342.31% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $7.63 | +31.06% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $2.48 | +585.48% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $4.81 | +3,351.14% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $5.25 | +1,042.86% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $2.25 | +10,566.67% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.63 | +856.63% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $4.48 | +7,935.71% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $3.47 | -42.42% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.29 | +355.93% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $1.28 | +681.25% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.17 | +373.19% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $10.86 | +912.89% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $960 | $4.84 | +19,755.22% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $11.54
Upside: +116.64%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $3.25
Upside: +238.46%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.65
Upside: +990.91%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $1.66
Upside: +803.61%
Leap Therapeutics
Jun 28, 2024
Initiates: Buy
Price Target: $8
Current: $0.32
Upside: +2,373.72%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.52
Upside: +2,988.80%
Adaptimmune Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $10
Current: $0.08
Upside: +12,920.83%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $0.94
Upside: +968.03%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $56.60
Upside: +32.51%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $63.76
Upside: -45.11%
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $1.75
Upside: +3,329.75%
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.47
Upside: +784.35%
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $7.22
Upside: +592.52%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.03
Upside: +1,356.31%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.37
Upside: +6,654.93%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $1.04
Upside: +1,342.31%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $7.63
Upside: +31.06%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $2.48
Upside: +585.48%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $4.81
Upside: +3,351.14%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $5.25
Upside: +1,042.86%
Jun 5, 2023
Reiterates: Buy
Price Target: $240
Current: $2.25
Upside: +10,566.67%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.63
Upside: +856.63%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $4.48
Upside: +7,935.71%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $3.47
Upside: -42.42%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $3.29
Upside: +355.93%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $1.28
Upside: +681.25%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $3.17
Upside: +373.19%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $10.86
Upside: +912.89%
Mar 2, 2020
Initiates: Buy
Price Target: $960
Current: $4.84
Upside: +19,755.22%